India has developed Asia's first indigenous CAR-T therapy — delivering breakthrough cancer treatment at a fraction of what it costs in the West.
A cancer diagnosis is one of the most terrifying moments a family can face. But treatment options — and outcomes — have changed dramatically. India is now home to some of the world's most advanced oncology centres, offering immunotherapy, targeted therapy, and the world's most affordable CAR-T cell therapy.
For patients who cannot access or afford treatment in the United States, United Kingdom, or Europe, India's cancer care ecosystem represents a genuine, medically equivalent alternative. This guide explains what is available, which hospitals offer it, and how indiCare helps you navigate every step.
Developed jointly by ImmunoACT and IIT Bombay, NexCAR19 is India's first homegrown CAR-T cell therapy, approved for B-cell lymphomas and leukaemias. It costs approximately $40,000–$50,000 in India — compared to $400,000–$500,000 in the United States for similar therapies. Same science. Fraction of the price.
Chimeric Antigen Receptor T-cell therapy reprograms a patient's own immune cells to target and destroy cancer cells. NexCAR19, developed in India, is approved for relapsed or refractory B-cell cancers.
From $40,000 in IndiaDrugs like pembrolizumab (Keytruda) and nivolumab (Opdivo) block proteins that prevent immune cells from attacking tumours. India offers branded and generic versions at significantly reduced costs.
60–80% cheaper than USAGenomic profiling and targeted drugs (EGFR inhibitors, ALK inhibitors, HER2 therapies) are widely available across major Indian oncology centres, guided by next-generation sequencing.
Full NGS from $800Advanced radiation techniques including Intensity-Modulated Radiation Therapy (IMRT) and proton beam therapy are available at facilities like Apollo Proton Cancer Centre in Chennai.
Proton from $20,000Da Vinci robotic surgery is available for prostate, gynaecological, and gastrointestinal cancers, enabling faster recovery, less blood loss, and smaller incisions.
70% cheaper than USABoth autologous and allogeneic stem cell transplants are performed at major centres in Mumbai, Delhi, Chennai, and Hyderabad, with outcomes comparable to Western transplant units.
From $25,000"The availability of CAR-T therapy in India — at a tenth of the Western cost — is not just an economic development. It is a humanitarian one. It means patients who would otherwise have no options, now do." — Dr. Hasmukh Jain, Haematologist, Tata Memorial Centre
indiCare works with a curated network of JCI and NABH-accredited cancer hospitals. Each is selected based on clinical outcomes, international patient experience, and availability of advanced therapies.
Send us your pathology reports, scans, and current treatment history. Everything is handled confidentially and assessed by our medical team within 24 hours.
We match you with the right hospital and specialist based on your specific cancer type, stage, and required treatment. You receive a detailed cost estimate before committing to anything.
Before you travel, your assigned specialist reviews your case in a video consultation. You ask every question, and your treatment plan is confirmed.
Medical visa invitation letter, airport pickup, accommodation near the hospital, and a dedicated indiCare coordinator who stays with you throughout your stay.
Your oncology team delivers treatment. Before you return home, indiCare ensures your follow-up protocol is fully documented and your local doctors are briefed.
Cancer does not wait, and neither should your access to the best possible care. If you or someone you love has received a cancer diagnosis and you want to explore what India's hospitals can offer — reach out to indiCare today. There is no fee for patients, no obligation, and no delay in getting answers.
Share your reports. Get a hospital match, treatment plan, and cost estimate — within 24 hours. No fees for patients.
Contact indiCare